Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
March 13, 2021
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine <i>In Vivo</i> Synergism
Young Hee Choi, Chao Zhang, Zhenzhen Liu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 10, 2019
A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression
Zhenzhen Liu, Mei-Juan Tu, Chao Zhang, et al.
Pharmacological Research
|
June 24, 2022
Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy
Hongye Zou, Yatian Yang, Zhenrui Shi, et al.
Biochemical Pharmacology
|
July 12, 2002
Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro
Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, et al.
Biochemical Pharmacology
|
January 12, 2011
Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells
Xin Li, Yu-Zhuo Pan, Gail M Seigel, et al.
Scientific Reports
|
May 25, 2016
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Yong Zhao, Mei-Juan Tu, Wei-Peng Wang, et al.
Acta Pharmaceutica Sinica. B
|
January 30, 2020
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics
Wanrong Yi, Mei-Juan Tu, Zhenzhen Liu, et al.
Pharmacogenetics
|
March 6, 2003
Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6
Ai-Ming Yu, Jeffrey R Idle, Linda G Byrd, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 7, 2013
Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport
Magnus Ingelman-Sundberg, Xiao-Bo Zhong, Oliver Hankinson, et al.
Biopharmaceutics & Drug Disposition
|
July 29, 2011
MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines
Alice C Rodrigues, Xin Li, Laura Radecki, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
The Journal of Pharmacology and Experimental Therapeutics
|
March 13, 2021
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine <i>In Vivo</i> Synergism
Young Hee Choi, Chao Zhang, Zhenzhen Liu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 10, 2019
A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression
Zhenzhen Liu, Mei-Juan Tu, Chao Zhang, et al.
Pharmacological Research
|
June 24, 2022
Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy
Hongye Zou, Yatian Yang, Zhenrui Shi, et al.
Biochemical Pharmacology
|
July 12, 2002
Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro
Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, et al.
Biochemical Pharmacology
|
January 12, 2011
Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells
Xin Li, Yu-Zhuo Pan, Gail M Seigel, et al.
Scientific Reports
|
May 25, 2016
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest
Yong Zhao, Mei-Juan Tu, Wei-Peng Wang, et al.
Acta Pharmaceutica Sinica. B
|
January 30, 2020
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics
Wanrong Yi, Mei-Juan Tu, Zhenzhen Liu, et al.
Pharmacogenetics
|
March 6, 2003
Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6
Ai-Ming Yu, Jeffrey R Idle, Linda G Byrd, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 7, 2013
Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport
Magnus Ingelman-Sundberg, Xiao-Bo Zhong, Oliver Hankinson, et al.
Biopharmaceutics & Drug Disposition
|
July 29, 2011
MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines
Alice C Rodrigues, Xin Li, Laura Radecki, et al.
Page
of 14